Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism

Cited by (197)

Items 101–197 of 197

1. Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?
   Agathe Dumont, Didier Dewailly, Pauline Plouvier, Sophie Catteau-Jonard, Geoffroy Robin · 2016 · Reproductive Biology and Endocrinology
2. Oligomenorrhoea in Exercising Women
   Susan Awdishu, N. Williams, S. Laredo, M. D. De Souza · 2009 · Sports Medicine
3. Insulin resistance in polycystic ovary syndrome phenotypes and the vicious cycle model in its etiology
   Piotr Robert Szkodziak, Filip Szkodziak, Kamila Trzeciak, Sławomir Woźniak, Margaret Mlynarczyk, Tomasz Paszkowski · 2025 · Scientific Reports
4. Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?
   Suvarna Satish Khadilkar · 2016 · The Journal of Obstetrics and Gynecology of India
5. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study
   Fatemeh Mahboobifard, Maryam Rahmati, Mina Amiri, Fereidoun Azizi, Fahimeh Ramezani Tehrani · 2022 · Advances in Medical Sciences
6. Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome
   Mahnaz Ashrafi, Fatemeh Sheikhan, Arezoo Arabipoor, Nicole A. Rouhana, Roya Hosseini, Zahra Zolfaghari · 2017 · Oman Medical Journal
7. Diagnóstico del Síndrome de Ovario Poliquístico: nuevos fenotipos, nuevas incógnitas
   Paulina M. Merino, Carolina Schulin-Zeuthen P, Ethel Codner D · 2009 · Revista médica de Chile
8. Reproductive System Outcome Among Patients with Polycystic Ovarian Syndrome
   Enrico Carmina · 2015 · Endocrinology and Metabolism Clinics of North America
9. Editorial commentary: What's in a number? The polycystic ovary revisited
   N. J. Raine‐Fenning · 2011 · Human Reproduction
10. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
    Barber, Thomas M, Franks, Stephen · 2013 · Expert Review of Endocrinology & Metabolism
11. A comparison of two- and three-dimensional ultrasonographic methods for evaluation of ovarian follicle counts and classification of polycystic ovarian morphology
    Heidi Vanden Brink, Adrienne J. Pisch, Marla Elaine Lujan · 2021 · Fertility and Sterility
12. The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome
    Thomas M. Barber, Petra Vojtechova, Stephen Franks · 2013 · Hormone Molecular Biology and Clinical Investigation
13. Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
    Eleni Armeni, Irene V. Lambrinoudaki · 2018 · Current Vascular Pharmacology
14. Polycystic Ovary Syndrome and Obesity
    Thomas M. Barber, Georgios K. Dimitriadis, Stephen Franks · 2015 · Springer eBooks
15. Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes
    Yue Zhao, Xiangyan Ruan, Alfred Otto Mueck · 2015 · Gynecological Endocrinology
16. Evaluation of Hormonal Profile and Ovarian Morphology among Adolescent Girls with Menstrual Irregularities in a Tertiary Care Centre at Central India
    Shweta Patel, Kameshwarachari Pushpalatha, Bharti Singh, Ragini Shrivastava, Gyanendra Singh, Deepti Dabar · 2022 · The Scientific World JOURNAL
17. Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome
    Selçuk Selçuk, Enis Özkaya, Ahmet Eser, Melda Kuyucu, Hüseyin Tayfun KUTLU, Belgin Devranoğlu, Kenan Sofuoğlu, Vedat Dayıcıoğlu · 2016 · Journal of Turkish Society of Obstetric and Gynecology
18. The numbers of 2– 5 and 6–9 mm ovarian follicles are inversely correlated in both normal women and in polycystic ovary syndrome patients: what is the missing link?
    Maëliss Peigné, Sophie Catteau-Jonard, Geoffroy Robin, A Dumont, Pascal Pigny, Didier Dewailly · 2018 · Human Reproduction
19. Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS
    Subarna Mitra, Gautom Kumar Saharia, Saubhagya Kumar Jena · 2023 · Annales d Endocrinologie
20. Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women
    Xue Zhang, Li Fu, Qiufang Zhang, Liying Yan, Yanmin Ma, Binbin Tu, Nana Liu, Jie Qiao · 2011 · Reproductive Biology and Endocrinology
21. Diagnosis and Management of Polycystic Ovary Syndrome
    Diamanti-Kandarakis, Evanthia, Farid, Nadir R · 2009 · Springer eBooks
22. Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19
    Solmaz Babaei Bonab, Maria Parvaneh · 2023 · Science & Sports
23. Le syndrome des ovaires polykystiques (SOPK)
    Antoine Torre, Hervé Fernandez · 2007 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
24. Anti-Müllerian hormone as a driving force of polycystic ovary syndrome, independently from insulin resistance
    Geoffroy Robin, Marie Deknuydt, Anne‐Laure Barbotin, Pascal Pigny, Sophie Catteau-Jonard, Didier Dewailly · 2021 · Reproductive BioMedicine Online
25. Baseline Scan and Ultrasound Diagnosis of PCOS
    CB Nagori · 2012 · Donald School Journal of Ultrasound in Obstetrics & Gynecology
26. Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
    Murat Şahin, Didem Demircioğlu, Ayten Oğuz, Dilek Tüzün, Mehmet Akif Sarıca, Elif İnanç, Kamile Gül · 2016 · Archives of Endocrinology and Metabolism
27. Sexual function in Chinese women with different clinical phenotypes of polycystic ovary syndrome
    Xuanxuan Tian, Xiangyan Ruan, Juan Du, Jiaojiao Cheng, Rui Jü, Alfred Otto Mueck · 2023 · Gynecological Endocrinology
28. ESPECTRO FENOTÍPICO DEL SÍNDROME DE OVARIO POLIQUÍSTICO
    Rodrigo Carvajal G, Cristian Herrera G, Arnaldo Porcile J · 2010 · Revista chilena de obstetricia y ginecología
29. COMPLICATIONS OF PREGNANCY IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
    Mallika Azizia, Paul James Hardiman · 2011 · Fetal and Maternal Medicine Review
30. Age‐related diagnostic threshold of anti‐Müllerian hormone for polycystic ovarian syndrome
    Vivek Kakkad, Sanjeeva Reddy, Harsh Nihlani, Tejas Gundewar · 2020 · International Journal of Gynecology & Obstetrics
31. Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
    Lígia Gabrielli, Maria da Conceição Chagas de Almeida, Estela M. L. Aquino · 2015 · Maturitas
32. Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)
    Neoklis AG, Anastasia KA · 2016 · Journal of Steroids & Hormonal Science
33. Serum sclerostin level and its relation to subclinical atherosclerosis in the polycystic ovary syndrome phenotypes: A prospective controlled study
    Feyza Nur İncesu Çintesun, Ümmügülsüm Can, Ersin Çintesun, Ayşegül Altunkeser, Aybike Kaya, Oğuzhan Günenç · 2021 · Journal of Turkish Society of Obstetric and Gynecology
34. CLINICAL PRESENTATION OF POLYCYSTIC OVARY SYNDROME AMONG SAUDI ARABIAN WOMEN – JEDDAH – SAUDI ARABIA.
    NajlaAbdullahh Alsibyani, Mohammed A. Malibary, Ahmad Ayed Derham, Abdulrahman Abdulelah Almnabri, NuhaKhalid Jazzar, Rzan Waleed Melibari, ReemAaidh Alnefayi, AlanoudSaed Alnefaie · 2017 · International Journal of Advanced Research
35. The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome
    Nefise TANRIDAN OKÇU, Hakan Nazik, Ayşe Topçu Akduman, Gürkan Uncu · 2017 · The European Research Journal
36. Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?
    Pauline Plouvier, Maëliss Peigné, Héloïse Gronier, Geoffroy Robin, Sophie Catteau-Jonard, Didier Dewailly · 2016 · Gynecological Endocrinology
37. Evaluation of metabolic, hormonal and clinical parameters in different phenotypes of polycystic ovary syndrome: an observational study from a tertiary care centre in Eastern India
    Kingshuk Bhattacharjee, Basu Asish Kumar, Anirban Sinha, Subir Swar, Animesh Maiti, Devarbhavi Praveen · 2018 · Journal of Diabetes Metabolic Disorders & Control
38. Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology
    Miro Šimun Alebić, Nataša Stojanović, Dinka Pavičić Baldani, Lea Smircic Duvnjak · 2016 · Endocrine
39. Anti-mullerian hormone and antral follicle count in polycystic ovary syndrome and non-polycystic ovary syndrome women
    Jwan Namik, Shahla Alalaf, Namir Al Tawil · 2018 · Zanco Journal of Medical Sciences
40. Phenotypic Variation of Polycystic Ovary Syndrome
    Gun Woo Pyun, Young Ju Choi, Hyejin Lee, Jee Young Oh, Young Sun Hong, Yeon‐Ah Sung, Hye Won Chung · 2007 · Journal of Korean Endocrine Society
41. Lipid variations in different polycystic ovary syndrome phenotypes: A systematic review & meta-analysis
    Naina Mishra, Prabhakar Mishra, Vishwas Kapoor, Jai Kishun, Anup Kumar, Uttam Singh · 2025 · The Indian Journal of Medical Research
42. Association between Anti-Müllerian Hormone and other biomarkers with ovarian function in polycystic ovarian syndrome of Iraqi women
    Huda B. Al-Lami, Fadhil Jawad Al-Tu’ma, Wasan Ghazi Al Safi · 2020 · Journal of Contemporary Medical Sciences
43. Prevalence of various phenotypes of polycystic ovarian syndrome among high school girls of Shiraz (2009)
    Tahereh Naderi, Marzieh Akbarzadeh, Mohammad Hossein Dabbaghmanesh, H R Tabatabaei · 2012 · The Journal of Qazvin University of Medical Sciences
44. Serum FSH level is lower in dysovulating than in ovulating non-PCOS obese women, independently of body mass index
    Sophie Catteau-Jonard, Anne Brunel, Agathe Dumont, Geoffroy Robin, Pascal Pigny, Didier Dewailly · 2019 · Annales d Endocrinologie
45. Pathophysiology of Ovarian Function in the Human Female
    Stephen Franks, Kate Hardy, Gerard S. Conway · 2014 · Elsevier eBooks
46. Impact of Hypocaloric Dietary Intervention on Phenotypic Presentations of Polycystic Ovary Syndrome (PCOS)
    Faith E Carter, Brittany Y Jarrett, Alexis L Oldfield, Heidi Vanden Brink, Joy Y. Kim, Marla Elaine Lujan · 2025 · Nutrients
47. Nutrition et infertilité féminine
    Anne Claire Donnadieu, Maud Pasquier, Céline Meynant, Jean‐Noël Hugues, Isabelle Cédrin‐Durnerin · 2009 · Cahiers de Nutrition et de Diététique
48. An Overview of Hyperandrogenism in PCOS and the Prospective Underlying Factors
    S. Abinaya, Durairaj Siva, R. Sabitha, Shanmugam Achiraman · 2019 · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences
49. Pathogenesis and Management of Adiposity and Insulin Resistance in Polycystic Ovary Syndrome (PCOS)
    Thomas M. Barber, Jalini Joharatnam, Stephen Franks · 2017 · Contemporary Endocrinology
50. How good are we at diagnosing polycystic ovary syndrome?
    Stephen Franks · 2007 · Clinical Endocrinology
51. The Frequency of Various Phenotypes of Polycystic Ovarian Syndrome in Adolescents, Based on Rotterdam Criteria
    Marzieh Akbarzadeh, Tahereh Naderi, Mohammad Hossein Dabbagh manesh, Hamid Reza Tabatabaee · 2015 · International Journal of School Health
52. Multiomics in polycystic ovarian syndrome
    Farhat Jabeen, Rais Ahmad, Seerat Rasool, Aarif Ali, Showkat Ahmad Ganie · 2024 · Elsevier eBooks
53. Le syndrome des ovaires polymicrokystiques (SOPMK)
    Didier Dewailly, Sylvie Hiéronimus, Pascale Mirakian, Jean‐Noël Hugues · 2010 · Annales d Endocrinologie
54. Age specific references for anti-mullerian hormone and use as a potential diagnostic marker of PCOS in an Indian population
    Abinaya Vijayan, Kundavi Shankar, Geetha Geetha · 2022 · Indian Journal of Obstetrics and Gynecology Research
55. The Hypothalamic–Pituitary Axis in PCOS
    Sabrina Gill, Janet Elizabeth Hall · 2013 · Springer eBooks
56. GnRH-receptor antagonism as a targeted approach to reproductive dysfunction in polycystic ovary syndrome
    Ludovica Cotellessa, Hélène Maitre, Frank Giton, Silvia Bongiovanni, Pascal Pigny, Geoffroy Robin, Sophie Catteau-Jonard, Paolo Giacobini · 2026 · EBioMedicine
57. An Investigation of Biochemical and Structural Changes in Reproductive System Hyperandrogenism in Experimental Letrozole-induced Polycystic Ovary Syndrome in Rat
    Azam Soleimani, Mohammad Saleh Rasoli, Reza Heidari, Abbas Ahmadi · 2016 · DOAJ (DOAJ: Directory of Open Access Journals)
58. PEDIATRIC REVIEW Polycystic ovary syndrome in adolescents
    Stephen Franks · 2008
59. Clinical and Hormonal Profile in Non Obese Women of Polycystic Ovarian Syndrome
    Dr Jyoti Bindal · 2018 · Journal of Medical Science And clinical Research
60. Excessive Androgen Exposure as an Etiological Factor of Polycystic Ovary Syndrome
    Tsuyoshi Baba, Toshiaki Endo, Sayaka Adachi, Keiko Ikeda, Ayumi Shimizu, 美幸 森下, Yoshika Kuno, Hiroyuki Honnma, Tamotsu Kiya, Tsuyoshi Saito · 2014 · Journal of Mammalian Ova Research
61. Is there a correlation between heart rate recovery and androgen parameters in polycystic ovary syndrome? Heart rate recovery in polycystic ovary syndrome
    Karee Angu, Renuka Sharma, Waqas Alauddin, Musharaf Bashir, Shams Aaghaz · 2022 · International Journal of Health Sciences
62. Surgical Management Options for Patients with Infertility and Endometriosis
    Michelle Catenacci, Tommaso Falcone · 2010 · Current Women s Health Reviews
63. Polycystic Ovary Syndrome, Obesity and Insulin Resistance
    Samantha Cassar · 2014 · Victoria University Research Repository (Victoria University)
64. Relationship Between Insulin Resistance and Serum Androgens Levels in Women With and Without PCOS by Rotterdam Diagnosis Criteria
    Maryam Movahedinejad, Saeide Ziaei, Anooshiravan Kazemnezhad, Zahra Kamali · 2021 · Research Square
65. Efeito do anticoncepcional oral sobre as alterações de metaloproteinases da matriz extracelular em pacientes com síndrome do ovário policístico
    Valéria A. Gomes · 2012
66. Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome
    Myint Myint Aye · 2013 · Repository@Hull (Worktribe) (University of Hull)
67. The Menstrual Cycle in PCOS
    Sabrina Gill, Janet Elizabeth Hall · 2009 · Springer eBooks
68. Síndrome de ovario poliquístico en la adolescente
    Samantha M. Pfeifer, Sari Leanne Kives · 2009 · Clínicas obstétricas y ginecológicas de Norteamérica
69. Variations in the Expression of the Polycystic Ovary Syndrome Phenotype
    Enrico Carmina · 2008 · Humana Press eBooks
70. Clinical Manifestation of Polycysticv Ovary Syndrome
    Yu‐Bae Ahn · 2007 · Journal of Korean Endocrine Society
71. Le syndrome des ovaires polykystiques
    Antoni Estradé · 2008 · Annales d Endocrinologie
72. Umwelteinflüsse beim polyzystischen Ovarsyndrom
    Susanne Tan, Dagmar Führer‐Sakel · 2015 · Gynäkologische Endokrinologie
73. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome : the utility of serum
    W androstenedioneMichael · 2015
74. Oligomenorrheic Girls without Evidence of Hyperandrogenism Serum Anti-Müllerian Hormone Concentrations Are Elevated in
    Jeffrey Chang, Alice S. Park, Mark A. Lawson, Sandy S. Chuan, Sharon E. Oberfield, Kathleen M. Hoeger, Selma Feldman Witchel · 2010
75. Pathogenesis and Management of Adiposity and Insulin Resistance in PCOS: Prevention and Treatment of the Metabolic Disease Components
    Stephen Franks, Jalini Joharatnam · 2010 · Springer eBooks
76. Unravelling the link between insulin resistance and androgen excess
    Michael O’Reilly · 2015 · University of Birmingham Institutional Research Archive (University of Birmingham)
77. Polikistik over sendromlu adolesanlarda serum adiponektin düzeyleri ile klinik, metabolik ve hormonal belirteçlerin ilişkisi
    Ayşe Deniz Ertürk Coşkun, Mehmet Can Keven, Nadire Sevda İdil, Levent Yaşar · 2012 · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy
78. Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years
    Marzieh Akbarzadeh, Tahereh Naderi, M H Dabbaghmaneh, Hamidreza Tabatabaee · 2016 · Journal of South Asian Federation of Obstetrics and Gynaecology
79. Risk reduction strategies for assisted conception in women with polycystic ovary syndrome
    Susan Louise Nicholas · 2015 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
80. LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo
    M. L. Hendriks, ML Hendriks, J.G. Brouwer, Peter G.A. Hompes, Roy Homburg, Cornelis Bavo Lambalk · 2008
81. Dietary management of Polycystic ovary syndrome.
    Lisa Moran · 2007 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
82. Gestational Diabetes Mellitus in Women with Polycystic Ovary Syndrome Undergoing Assisted Reproduction
    Tran Thi Minh Chau, Lan N. Vuong · 2018 · Y HOC TP HO CHI MINH
83. Evaluación de parámetros endócrino metabólicos en los nuevos fenotipos diagnósticos de pacientes con síndrome de ovario poliquístico
    Carolina Fux Otta · 2012
84. Current World Literature
    2007 · Current Opinion in Obstetrics & Gynecology
85. Characteristics of Different Phenotypes of Polycystic Ovary Syndrome in a Turkish Population: a Prospective Study
    Bahadır ERTÜRK, Recai Pabuçcu, Nafiye Yılmaz, Esra İşçi Bostancı, Hakan Tımur, Emre Pabuçcu, Tufan Arslanca, Müge Keskin · 2021 · Türk Üreme Tıbbı ve Cerrahisi Dergisi
86. Faculty Opinions recommendation of Polycystic ovary syndrome throughout a woman's life.
    Fernando Marcos dos Reis · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
87. The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome
    Mohamed Kandil · 2022 · Qeios
88. The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome
    Mohamed Kandil · 2022 · Qeios
89. The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome
    Mohamed Kandil · 2022 · Qeios
90. The Polyfollicular Anovulatory Hyperandrogenic Syndrome: A New Label for an Old Syndrome
    Mohamed Kandil · 2023 · Qeios
91. Polycystic ovary syndrome phenotypes
    Unab Inayat Khan, Rubia Farid · 2023 · Elsevier eBooks
92. Associated risk factors of Poly Cystic Ovarian disease in gynecologist refer; King Saud Medical City Riyadh Saudi Arabia
    Ibtesam Fawaz Alshammari, Fawaz Abdullah Ibrahim Alabdan, Rakan Hassan Marghlani, Ibrahim smail Hamami, Abdulaziz Abdo Ali Agili, Sultan Hamed Alanazy, Abdullah Ahmed Mohamed Ghouth, Saad Khaleel Alonze, Mohamed Sidig Ahmed Mokhtar, Alanazi Salha Aowad · 2023 · Medical Science
93. The Impact of Hyperandrogenism in Female Obesity and Cardiometabolic Disease Associated with Polycystic Ovary Syndrome
    Thomas M. Barber, Petra Hanson, Stephen Franks · 2024 · Springer eBooks
94. Mécanismes d'action de l'Œstradiol dans l'ovaire humain en conditions physiologique et polykystique
    Clémentine Marie · 2024
95. Evaluation of Understanding and Lifestyle Practices Regarding Polycystic Ovary Syndrome Among Females
    Naoor Al_huda Anwar · 2026 · IFR Journal of Nursing and Health Care Prevention
96. Polycystic ovary syndrome - morphologic and dynamic evaluation by magnetic resonance imaging
    Henrik Leonhardt · 2013 · Gothenburg University Publications Electronic Archive (Gothenburg University)
97. The Risk of Diabetes and Metabolic Syndrome in PCOS
    Thomas M. Barber · 2009 · Springer eBooks